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Abstract In the nematode Caenorhabditis elegans apoptosis is 
tightly regulated by a hierarchical set of genes. Two of these, 
ced-3 and ced-9, possess mammalian homologues encoding 
executional ICE proteases and inhibitory Bcl-2-related proteins, 
respectively. The function of a third key player, ced-4, is however 
completely unknown and no mammalian counterparts have been 
identified. Here we report that Ced-4 protein contains a 
structural region with similarity to the mammalian death effector 
domain which has previously been demonstrated to act as an 
important protein interaction motif in the signaling pathway of 
the mammalian surface receptor Fas (APO-1, CD95). Based on 
this finding and previously described genetic experiments, we 
propose that Ced-4, similar to the mammalian proteins FADD 
and FLICE, may possess a function as an adaptor protein in 
invertebrate apoptotic pathways. 
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domain; FADD; FLICE 
1. Introduction 
A hallmark of apoptosis is not only that morphological 
alterations are quite uniform but also that the genetic machi-
nery controlling cell death is highly conserved. In mammalian 
cells, major inducers of apoptosis include Fas (APO-1, CD95) 
and TNF-RI, two related surface receptors that mediate cell 
death in various target cells [1,2]. Both receptors contain an 
intracellular domain of about 70 amino acids which is essen-
tial for transmission of the apoptotic signal and has therefore 
been called the 'death domain' (DD) [3]. The DD sequence 
acts as an interface by recruiting other proteins to the recep-
tor. One of these is FADD (MORT-1), a bipartite molecule 
which in its C-terminus contains a DD sequence mediating 
DD-DD interaction with the Fas receptor [4,5]. 
In its N-terminus FADD has a second protein motif which 
is required to trigger apoptosis and has been designated the 
'death effector domain' (DED). The N-terminal part of 
FADD alone is sufficient for apoptosis, whereas N-terminal 
truncations of FADD act as dominant-negative inhibitors of 
Fas-triggered apoptosis [4,5]. Thus, the DED sequence defines 
a protein interaction motif that through the adaptor protein 
FADD couples distal effector molecules to the receptor. Very 
recently, two groups have succeeded in the identification of 
such a receptor-associated effector component, called FLICE 
(MACH) [6,7]. FLICE contains two tandem DED regions 
with homology to FADD that mediate FADD/FLICE inter-
action. At its C-terminus FLICE possesses a proteolytically 
active region homologous to the interleukin-lß-converting en-
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zyme (ICE) proteases. ICE proteases are an emerging family 
of cysteine proteases that have been implicated as the key 
executioners in apoptosis [8-10]. It is assumed that recruit-
ment of FADD to the receptor somehow leads to processing 
of the inactive FLICE precursor to the active protease. Acti-
vation of FLICE may then trigger one or more other ICE 
proteases resulting in the final destruction of the cell's archi-
tecture. 
Important for our understanding of apoptosis was the find-
ing that the basic machinery controlling cell death is highly 
conserved in mammals and invertebrates. Of the three genes 
that regulate apoptosis in Caenorhabditis elegans, two, ced-3 
and ced-4, are required for the execution of cell death [11]. In 
contrast, another gene, ced-9, protects cells that normally sur-
vive from undergoing programmed cell death. Loss-of-func-
tion mutations in ced-9 cause cells that normally live instead 
of undergoing programmed cell death. The excess cell deaths 
require the activity of ced-3 and ced-4, indicating that ced-9 
acts by preventing ced-3 and ced-4 from causing cell death. 
Both ced-9 and ced-3 have known mammalian counterparts 
that function in cell death. Ced-9 is the structural and func-
tional homologue of bcl-2, one of a family of genes intimately 
involved in prevention of vertebrate apoptosis [12]. Ced-3 en-
codes a protease related to ICE members, the essential execu-
tioners of apoptosis in mammals [13]. In contrast, the function 
of ced-4 is completely obscure and as yet no mammalian ho-
mologue has been identified [14]. Mutations in either ced-3 or 
ced-4 block all naturally occurring cell death in C elegans, 
suggesting that both gene products may converge on the same 
signaling pathway [15]. 
In this report we have performed a detailed sequence anal-
ysis of the Ced-4 protein. It is demonstrated that Ced-4 con-
tains a region with similarity to the DED sequence of the 
recently identified mammalian proteins FADD and FLICE. 
We propose that, in analogy the mammalian apoptotic path-
way, Ced-4 may act as an adaptor protein activating Ced-3 
protease activity during execution of invertebrate cell death. 
2. Materials and methods 
Protein sequences were retrieved from the GenBank and Swiss-Prot 
databases. Homology searches were performed using the BLAST and 
FASTA programs which were accessed by WWW servers. Alignments 
were constructed using the BLOSUM 45 and other available similarity 
matrices with default gap penalties. Statistical significance of similar-
ities was evaluated by regional shuffling and the MACAW 2.0.3. al-
gorithm [16]. Secondary structures were predicted using the PHDsec 
program [17] which is available at the EMBL server. 
3. Results and discussion 
Recent genetic analysis has shown that overexpression of 
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Fig. 1. A: Sequence alignment of Ced-4 (N-terminal region) with the death effector domains (DED) of human FADD (MORT-1), FLICE 
(MACH) and PEA-15. Numbers give the position of amino acids in each sequence. Amino acids identical in two sequences are marked by blue 
boxes if including Ced-4, and in yellow boxes if not including Ced-4. The secondary structures were predicted using PHD [16] and are shown 
beneath the alignment (1, loop; h, a-helix). The Genbank and Swiss-Prot accession numbers were U24231 for human FADD, U58143 for hu-
man FLICE, X86694 for PEA-15, and X69016 for Ced-4. B: Proposed functional analogy of apoptosis in mammals and C. elegans. In mam-
malian cells, activation of the surface receptors Fas and TNF-RI triggers an apoptotic signal which results in activation of FLICE and other 
ICE proteases, such as ICE, CPP32 and ICE-LAP3. The signal is transduced through recruitment of FADD and FLICE to the receptor. The 
interaction of Fas and FADD is due to the association of their respective death domains (DD). In turn, FADD recruits FLICE through bind-
ing to the death effector domains (DED) and somehow activates FLICE proteolytic activity. In C. elegans, the functional homologue of ICE 
proteases is Ced-3. Ced-4 is thought to act upstream of Ced-3, possibly through its DED motif. Apoptosis is prevented by the Bcl-2 homologue 
Ced-9 which presumably inhibits Ced-4 activity. 
ced-4 requires ced-3 function, whereas overexpression of ced-3 that ced-4 acts presumably upstream of ced-3. Prompted by 
induces cell death independent of ced-4 [15]. This indicates this hierarchical order of the C. elegans death genes and the 
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recent elucidation of the proximal Fas signaling pathway, we 
performed a detailed analysis of the Ced-4 protein se-
quence. 
When Ced-4 was used for the database searches, no simi-
larity was found to mammalian death proteins. A closer in-
spection of the N-terminal region of Ced-4, however, revealed 
a similarity to the DED motif present in the Fas signaling 
components FADD and FLICE (Fig. 1A). Another DED-
containing protein, PEA-15, which has been identified as an 
astrocyte phosphoprotein of unknown function, contains an 
even higher degree of similarity. In the N-terminal part of 
Ced-4, a total number of 14 amino acids out of 71 are iden-
tical to PEA-15. Calculation of the probability of matching by 
chance using MACAW [15] yielded P-values in the range of 
10 - 2 to 10 - 5 . In addition, when gaps were inserted in the 
alignment as shown in Fig. 1A, a P-value of 6.8 X 10~18 was 
computed. 
It is noteworthy that in all sequences the similarities are 
localized near the N-terminus. Using the PHD program [16] 
a regular secondary structure of the aligned sequences was 
predicted consisting mainly of oc-helices in all proteins but 
not of ß-strand structures (Fig. 1A). 
The presence of a similar DED motif in Ced-4 therefore 
raises the possibility that Ced-4 acts as an adaptor and acti-
vator protein of Ced-3. Activation of Ced-4 could mediate 
protein interaction analogous to FADD and the N-terminus 
of FLICE and finally trigger Ced-3 protease activity (Fig. IB). 
This hypothesis is supported by genetic analysis demonstrat-
ing that Ced-4 activity depends on Ced-3 as a distal compo-
nent in the apoptotic pathway [15]. Furthermore, a mutation 
in the putative DED region of Ced-4 has been reported to 
abrogate apoptosis [14]. 
Although the functional importance of the DED-related 
sequence in Ced-4 has not yet been proven, further structural 
analysis should clarify the role of Ced-4 as an upstream acti-
vator of Ced-3 and functional homologue of FADD. In sum-
mary, our finding further supports the notion that the effector 
mechanisms of apoptosis are highly conserved in invertebrate 
and mammalian cells. 
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